Advances in the study of the anti-tumor activity of small molecule vascular disrupting agents / 药学学报
Acta Pharmaceutica Sinica
;
(12): 283-288, 2010.
Artículo
en Chino
| WPRIM
| ID: wpr-250590
ABSTRACT
Vascular disrupting agents (VDAs) have presented a new kind of anti-cancer drug in recent years. VDAs take advantage of the weakness of established tumor endothelial cells and their supporting structures. In contrast to anti-angiogenic therapy, which inhibits the outgrowth of new blood vessels, vascular targeting treatments selectively attack the existing tumor vasculature. Here we summarized the anti-tumor activities, mechanisms and clinical applications of small molecule VDAs.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Oligopéptidos
/
Compuestos Organofosforados
/
Patología
/
Farmacología
/
Serina
/
Estilbenos
/
Bibencilos
/
Estructura Molecular
/
Química
/
Difosfatos
Límite:
Animales
/
Humanos
Idioma:
Chino
Revista:
Acta Pharmaceutica Sinica
Año:
2010
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS